The overall purpose of the Survey Research Core (SRC) is to provide standardized services for conducting survey-based research. The SR(5 collects and manages survey-based research data for population-based studies. SRC utilizes a critical mass of highly trained personnel to maximize efficiency, reduce the cost and optimize participation rates from survey-based research. The Core services include: i) sample selection; ii) survey design and pre-testing; iii) implementing and monitoring mailed surveys; iv) conducting all aspects of telephone survey; v) implementation of all aspects of web-based survey; vi) tracking study subjects lost to follow-up; and vii) automated data entry. The SRC is located in the Department of Population Sciences that houses the vast majority of the Cancer Control and Population Sciences (CCPS) members. While the SRC serves primarily the members of the CCPS Program, it has also provided services to members of the Hematological Malignancies, and Developmental Cancer Therapeutics Programs interested in conducting research utilizing mailed, web-based, or telephone surveys for collecting exposure or outcome data. Dr. Can- Lan Sun has directed the Core since its inception in 2006. The staff of the SRC includes one Clinical Research Associate, and one MS-prepared Biostatistician, with close collaboration with and supervision by the Ph.D.-level Biostatistician. In order to handling mass mailing surveys and collecting high-quality data, the SRC utilizes Cardiff Teleform Information Capture System, an automated content capture system, and the DatStat Illume integrated platform to conduct web-based surveys. Since December 2007, SRC services have been utilized by 40 studies, resulting in the development of over 150 forms. The vast majority of the core's time has been spent on scannable form design/on-line survey design, scanning/ verification and database management Services provided by the SRC have resulted in several high impact publications.

Public Health Relevance

The overall goal of the Survey Research core facility is to conduct survey-based research to obtain data for population-based studies. The facility uses highly trained personnel and assist in sample selection, survey design, conduct surveys via phone and web, track study subjects for follow-up and develop automated data entry. This goal enhances the Cancer Center's dedication to developing innovative new disease-fighting strategies in the battle against cancer.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA033572-34
Application #
9179607
Study Section
Subcommittee I - Transistion to Independence (NCI)
Project Start
1997-08-01
Project End
2018-03-31
Budget Start
2016-12-01
Budget End
2017-11-30
Support Year
34
Fiscal Year
2017
Total Cost
Indirect Cost
Name
Beckman Research Institute/City of Hope
Department
Type
DUNS #
027176833
City
Duarte
State
CA
Country
United States
Zip Code
91010
Gong, Jun; Salgia, Ravi (2018) Managing Patients With Relapsed Small-Cell Lung Cancer. J Oncol Pract 14:359-366
Chen, Robert W; Palmer, Joycelynne M; Tomassetti, Sarah et al. (2018) Multi-center phase II trial of bortezomib and rituximab maintenance combination therapy in patients with mantle cell lymphoma after consolidative autologous stem cell transplantation. J Hematol Oncol 11:87
Romsdahl, Jillian; Blachowicz, Adriana; Chiang, Abby J et al. (2018) Characterization of Aspergillus niger Isolated from the International Space Station. mSystems 3:
Sen, Subha; He, Zhiheng; Ghosh, Shubhamoy et al. (2018) PRMT1 Plays a Critical Role in Th17 Differentiation by Regulating Reciprocal Recruitment of STAT3 and STAT5. J Immunol 201:440-450
Lueschow, Shiloh R; Stumphy, Jessica; Gong, Huiyu et al. (2018) Loss of murine Paneth cell function alters the immature intestinal microbiome and mimics changes seen in neonatal necrotizing enterocolitis. PLoS One 13:e0204967
Gu, Long; Lingeman, Robert; Yakushijin, Fumiko et al. (2018) The Anticancer Activity of a First-in-class Small-molecule Targeting PCNA. Clin Cancer Res 24:6053-6065
Zhao, Xingli; Zhang, Zhuoran; Moreira, Dayson et al. (2018) B Cell Lymphoma Immunotherapy Using TLR9-Targeted Oligonucleotide STAT3 Inhibitors. Mol Ther 26:695-707
Weitzel, Jeffrey N; Chao, Elizabeth C; Nehoray, Bita et al. (2018) Somatic TP53 variants frequently confound germ-line testing results. Genet Med 20:809-816
Ghose, Jayeeta; Viola, Domenico; Terrazas, Cesar et al. (2018) Daratumumab induces CD38 internalization and impairs myeloma cell adhesion. Oncoimmunology 7:e1486948
Aslamy, Arianne; Oh, Eunjin; Olson, Erika M et al. (2018) Doc2b Protects ?-Cells Against Inflammatory Damage and Enhances Function. Diabetes 67:1332-1344

Showing the most recent 10 out of 1396 publications